Crossbow Therapeutics

BiotechnologySeries BCambridge, UScrossbowtx.com

Latest round

Series B

Last raised

Mar 2026

Total raised

$115M

Investors

12

About Crossbow Therapeutics

Based in Massachusetts, US, and founded in 2021, Crossbow Therapeutics, Inc operates as a biotechnology that develops antibodies for cancer treatment. The company was Co-founded by Geraldine Paulus and others. In March 2023, Crossbow Therapeutics, Inc. The company develops antibody therapies to treat a broad range of cancers. The biotech company develops T-Bolt™ which helps T-cells receptor target cancer cells. The TCRm antibodies developed by the firm assemble T-Cell engagers and other immunotherapies which reduce tumors.

Who invested in Crossbow Therapeutics

12 investors across 2 rounds

See all investors in Crossbow Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Mar 18, 2026

    Amount

    $77M

    Investors

    Locked

  2. Series A

    Mar 29, 2023

    Amount

    $38M

    Investors

    Locked

Questions about Crossbow Therapeutics

Who invested in Crossbow Therapeutics?

Crossbow Therapeutics has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Crossbow Therapeutics raised?

Crossbow Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Crossbow Therapeutics last raise money?

Crossbow Therapeutics's most recent round on record is a Series B, in Mar 2026.

What does Crossbow Therapeutics do?

Based in Massachusetts, US, and founded in 2021, Crossbow Therapeutics, Inc operates as a biotechnology that develops antibodies for cancer treatment.

Where is Crossbow Therapeutics headquartered?

Crossbow Therapeutics is headquartered in Cambridge, US.

Which VCs invest in companies like Crossbow Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Crossbow Therapeutics's stage. Their profiles are linked below.

Raising like Crossbow Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.